Endogenous nitric oxide and soluble tumor necrosis factor receptor levels are enhanced in infants with congenital heart disease

Critical Care Medicine

Volumn 29, Issue 11, 2001, Pages 2208-2210

  Buchhorn, Reiner ^a   Wessel, Armin ^a   Hulpke Wette, Martin ^a   Bürsch, Joachim ^a   Werdan, Karl ^b   Loppnow, Harald ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Congenital heart disease; Cyanosis; Cytokines; Heart failure; Infant; Interleukin 1; Left to right shunt; Nitric oxide; Soluble tumor necrosis factor receptor; Tumor necrosis factor; blocker

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; INTERLEUKIN 1; NITRATE; NITRIC OXIDE; NITRITE; PROPRANOLOL; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CYANOTIC HEART DISEASE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEART LEFT RIGHT SHUNT; HUMAN; INFANT; LUNG BLOOD FLOW; PEDIATRICS; PRIORITY JOURNAL;

EID: 0035166281     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200111000-00026     Document Type: Article

References (10)

1. Cytokines in heart failure: Pathogenetic mechanisms and potential treatment
2. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure
3. Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations
4. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumor necrosis factor-alpha
5. The interleukin-1 and interleukin-1-converting enzyme families in the cardiovascular system
6. Beta-blocker therapy of severe heart failure in infants with left-to-right shunts
7. Nitric oxide production in critically ill patients
8. Enhanced TNF receptor and IL-10 levels are abrogated in metroprolol-treated CHF-patients
9. Plasma nitric oxide products correlate with cardiac index of congenital heart disease
10. Effect of the immunomodulating agent pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo-controlled, double-blind trial